Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Bioorganic Chemistry
|
February 24, 2018
Thiazolidinediones as antidiabetic agents: A critical review
M J Nanjan, Manal Mohammed, B R Prashantha Kumar, et al.
ACS Chemical Neuroscience
|
June 14, 2021
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics
Prabitha P, Antony Justin, T Durai Ananda Kumar, et al.
Bioorganic & Medicinal Chemistry
|
April 6, 2020
Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules
Krishnappa Ramya, Ramalingam Suresh, Honnavalli Yogish Kumar, et al.
RSC Medicinal Chemistry
|
December 19, 2024
Novel rhodanine-thiazole hybrids as potential antidiabetic agents: a structure-based drug design approach
Shankar Gharge, Shankar G Alegaon, Shriram D Ranade, et al.
Chirality
|
October 14, 2024
Enantioselective Separation and Pharmacokinetics of a Chiral 1,4-Dihydropyrimidine Derivative in Rats: A Combined Chromatography and Docking Approach
Chiriki Devi Sri, Syed Faizan, Muttavarapu Rohit Chandra, et al.
Chemistry Central Journal
|
December 21, 2018
Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies
Subhankar P Mandal, Aakriti Garg, P Prabitha, et al.
Bioorganic Chemistry
|
June 14, 2014
Design, synthesis and glucose uptake activity of some novel glitazones
Koyel Kar, Uma Krithika, Mithuna, et al.
Mini Reviews in Medicinal Chemistry
|
March 5, 2021
Glitazones, PPAR-γ and Neuroprotection
Ashwini Prem Kumar, Prabitha P, B R Prashantha Kumar, et al.
Current Drug Delivery
|
May 12, 2015
Dual Drug Conjugate Loaded Nanoparticles for the Treatment of Cancer
Megha Shyam Matlapudi, Afrasim Moin, Raghavender Medishetti, et al.
Bioorganic Chemistry
|
December 18, 2024
Beyond peptides: Unveiling the design strategies, structure activity correlations and protein-ligand interactions of small molecule inhibitors against PD-1/PD-L1
Pujan Sasmal, P Prabitha, B R Prashantha Kumar, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Bioorganic Chemistry
|
February 24, 2018
Thiazolidinediones as antidiabetic agents: A critical review
M J Nanjan, Manal Mohammed, B R Prashantha Kumar, et al.
ACS Chemical Neuroscience
|
June 14, 2021
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics
Prabitha P, Antony Justin, T Durai Ananda Kumar, et al.
Bioorganic & Medicinal Chemistry
|
April 6, 2020
Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules
Krishnappa Ramya, Ramalingam Suresh, Honnavalli Yogish Kumar, et al.
RSC Medicinal Chemistry
|
December 19, 2024
Novel rhodanine-thiazole hybrids as potential antidiabetic agents: a structure-based drug design approach
Shankar Gharge, Shankar G Alegaon, Shriram D Ranade, et al.
Chirality
|
October 14, 2024
Enantioselective Separation and Pharmacokinetics of a Chiral 1,4-Dihydropyrimidine Derivative in Rats: A Combined Chromatography and Docking Approach
Chiriki Devi Sri, Syed Faizan, Muttavarapu Rohit Chandra, et al.
Chemistry Central Journal
|
December 21, 2018
Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies
Subhankar P Mandal, Aakriti Garg, P Prabitha, et al.
Bioorganic Chemistry
|
June 14, 2014
Design, synthesis and glucose uptake activity of some novel glitazones
Koyel Kar, Uma Krithika, Mithuna, et al.
Mini Reviews in Medicinal Chemistry
|
March 5, 2021
Glitazones, PPAR-γ and Neuroprotection
Ashwini Prem Kumar, Prabitha P, B R Prashantha Kumar, et al.
Current Drug Delivery
|
May 12, 2015
Dual Drug Conjugate Loaded Nanoparticles for the Treatment of Cancer
Megha Shyam Matlapudi, Afrasim Moin, Raghavender Medishetti, et al.
Bioorganic Chemistry
|
December 18, 2024
Beyond peptides: Unveiling the design strategies, structure activity correlations and protein-ligand interactions of small molecule inhibitors against PD-1/PD-L1
Pujan Sasmal, P Prabitha, B R Prashantha Kumar, et al.
Page
of 5